Mark Connors talk about 2 different patient populations able to control HIV pathogenesis via their T cell or B cell responses.

Primate immunodeficiency virus proteins Vpx and Vpr and how they counteract transcriptional repression of proviruses by the HUSH complex.

At the 44th Retrovirus meeting at Cold Spring Harbor Laboratories, with John Coffin, Stephen Hughes, Ya-Chi Ho, and Matt Takata talking about the meeting and their work on HIV-1.

A virus designed to target cancer could also help eliminate hidden HIV infections!

Undermining of antiviral effectiveness by genital inflammation, and heterogeneity of influenza virus infection in single cells.

Multidisciplinary research is beginning to unveil connections between the gut microbiome and human health status disparities.

Daniel R. Kuritzkes, MD, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, gives a presentation on what the next steps are to eradication of HIV and AIDS at the American Society for Microbiology's 2016 Microbe Meeting in Boston for a symposium entitled New Frontiers in HIV Cure.

Vincent speaks with Gary Nabel, Chief Scientific Officer at Sanofi and former Director of the Vaccine Research Institute of NIAID, about his career and his work on HIV vaccines.

TWiV traces the early history of HIV in North America, based on genome sequences obtained from late 1970s archival sera, which also reveal that Gaetan Dugas was not Patient Zero.